TYLENOL® 8 HR Extended Release Caplets

TYLENOL® 8 HR Extended Release Caplets

Use only as directed.

This website contains the most current Drug Facts labeling information, and may differ from labels on product packaging you may have. If there are any differences between this website labeling and product packaging labeling, this website labeling should be regarded as the most current.

TYLENOL® 8 HR Extended Release Caplets

Use only as directed.

Description/Ingredients

Each TYLENOL® 8 HR Extended Release Caplet contains acetaminophen 650 mg.

TYLENOL® 8 HR Extended Release Caplets

Use only as directed.

Mechanism of Action

Acetaminophen is a clinically proven analgesic/antipyretic. Acetaminophen is thought to produce analgesia by elevation of the pain threshold and antipyresis through action on the hypothalamic heat-regulating center. Acetaminophen is equal to aspirin in analgesic and antipyretic effectiveness and it is unlikely to produce many of the side effects associated with aspirin and aspirin-containing products. TYLENOL® 8 HR Extended Release uses a bilayer gelcap/caplet. The first layer dissolves quickly to provide prompt relief while the second layer is time released to provide up to 8 hours of relief.

TYLENOL® 8 HR Extended Release Caplets

Use only as directed.

Uses

TYLENOL® 8 HR Extended Release Caplets:

  • temporarily relieves minor aches and pains due to:
    muscular aches, backache, headache, minor pain of arthritis
  • temporarily reduces fever
TYLENOL® 8 HR Extended Release Caplets

Use only as directed.

Dosage Information

TYLENOL® 8 HR Extended Release Caplets:

Adults and children 12 years and over

  • take 2 caplets every 8 hours with water
  • swallow whole - do not crush, chew, split or dissolve
  • do not take more than 6 caplets in 24 hours
  • do not use for more than 10 days unless directed by a doctor

Children under 12 years

  • do not use
TYLENOL® 8 HR Extended Release Caplets

Use only as directed.

Warnings

TYLENOL® 8 HR Extended Release Caplets

Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
  • more than 6 caplets in 24 hours, which is the maximum daily amount
  • with other drugs containing acetaminophen
  • 3 or more alcoholic drinks every day while using this product

Do not use

  • with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist
  • if you are allergic to acetaminophen or any of the inactive ingredients in this product

Ask a doctor before use if you have liver disease

Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin

Stop use and ask a doctor if

  • pain gets worse or lasts more than 10 days
  • fever gets worse or lasts more than 3 days
  • new symptoms occur
  • redness or swelling is present

These could be signs of a serious condition.

 

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

 

Other Information:

TYLENOL® 8 HR Extended Release Caplets

  • store between 20-25ºC (68-77ºF). Avoid excessive heat 40ºC (104ºF)
TYLENOL® 8 HR Extended Release Caplets

Use only as directed.

PROFESSIONAL INFORMATION: OVERDOSAGE INFORMATION

Acetaminophen: Acetaminophen in massive overdosage may cause hepatic toxicity in some patients. In adults and adolescents (>/= 12 years of age), hepatic toxicity may occur following ingestion of greater than 7.5 to 10 grams over a period of 8 hours or less. Fatalities are infrequent (less than 3-4% of untreated cases) and have rarely been reported with overdoses of less than 15 grams. In children (<12 years of age), an acute overdosage of less than 150 mg/kg has not been associated with hepatic toxicity. Early symptoms following a potentially hepatotoxic overdose may include: nausea, vomiting, diaphoresis and general malaise. Clinical and laboratory evidence of hepatic toxicity may not be apparent until 48 to 72 hours postingestion. In adults and adolescents, any individual presenting with an unknown amount of acetaminophen ingested or with a questionable or unreliable history about the time of ingestion should have a plasma acetaminophen level drawn and be treated with N-acetylcysteine. For full prescribing information, refer to the N-acetylcysteine package insert. Do not await results of assays for plasma acetaminophen levels before initiating treatment with N-acetylcysteine. The following additional procedures are recommended: Promptly initiate gastric decontamination of the stomach. A plasma acetaminophen assay should be obtained as early as possible, but no sooner than four hours following ingestion. If an acetaminophen extended release product is involved, it may be appropriate to obtain an additional plasma acetaminophen level 4-6 hours following the initial acetaminophen level. If either acetaminophen level plots above the treatment line on the acetaminophen overdose nomogram, N-acetylcysteine treatment should be continued for a full course of therapy. Liver function studies should be obtained initially and repeated at 24-hour intervals. Serious toxicity or fatalities have been extremely infrequent following an acute acetaminophen overdose in young children, possibly because of differences in the way they metabolize acetaminophen. In children, the maximum potential amount ingested can be more easily estimated. If more than 150 mg/kg or an unknown amount was ingested, obtain a plasma acetaminophen level as soon as possible, but no sooner than 4 hours following ingestion. If an acetaminophen extended release product is involved, it may be appropriate to obtain an additional plasma acetaminophen level 4-6 hours following the initial acetaminophen level. If either acetaminophen level plots above the treatment line on the acetaminophen overdose nomogram, N-acetylcysteine treatment should be initiated and continued for a full course of therapy. If an assay cannot be obtained and the estimated acetaminophen ingestion exceeds 150 mg/kg, dosing with N-acetylcysteine should be initiated and continued for a full course of therapy. For additional emergency information, call your regional poison center or call the Rocky Mountain Poison Center toll-free, (1-800-525-6115).

For additional emergency information, please contact your local poison control center.
(1-800-222-1222). Alcohol Information: Chronic heavy alcohol abusers may be at increased risk of liver toxicity from excessive acetaminophen use, although reports of this event are rare. Reports usually involve cases of severe chronic alcoholics and the dosages of acetaminophen most often exceed recommended doses and often involve substantial overdose. Healthcare professionals should alert their patients who regularly consume large amounts of alcohol not to exceed recommended doses of acetaminophen.

TYLENOL® 8 HR Extended Release Caplets

Use only as directed.

How Supplied

TYLENOL® 8 HR Extended Release Caplets

TYLENOL® 8 HR Extended Release Caplets – 650 mg

 

NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

TYLENOL® 8 HR Extended Release Caplets

Use only as directed.

Inactive Ingredients

TYLENOL® 8 HR Extended Release Caplets: corn starch, D&C yellow no. 10 aluminum lake, FD&C red no. 40 aluminum lake, FD&C yellow no. 6 aluminum lake, hydroxyethyl cellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, povidone, powdered cellulose, pregelatinized starch, sodium starch glycolate, sucralose, talc, titanium dioxide